Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Receivables - Other: 2019-2021

Historic Receivables - Other for Neurocrine Biosciences (NBIX) over the last 2 years, with Sep 2021 value amounting to $2.8 million.

  • Neurocrine Biosciences' Receivables - Other fell 20.00% to $2.8 million in Q3 2021 from the same period last year, while for Sep 2021 it was $2.8 million, marking a year-over-year decrease of 20.00%. This contributed to the annual value of $3.7 million for FY2020, which is N/A change from last year.
  • Per Neurocrine Biosciences' latest filing, its Receivables - Other stood at $2.8 million for Q3 2021, which was up 3.70% from $2.7 million recorded in Q2 2021.
  • Over the past 5 years, Neurocrine Biosciences' Receivables - Other peaked at $4.7 million during Q1 2020, and registered a low of $463,000 during Q3 2019.
  • Its 3-year average for Receivables - Other is $3.1 million, with a median of $3.4 million in 2020.
  • Its Receivables - Other has fluctuated over the past 5 years, first soared by 655.94% in 2020, then crashed by 31.91% in 2021.
  • Over the past 3 years, Neurocrine Biosciences' Receivables - Other (Quarterly) stood at $463,000 in 2019, then surged by 655.94% to $3.7 million in 2020, then fell by 20.00% to $2.8 million in 2021.
  • Its last three reported values are $2.8 million in Q3 2021, $2.7 million for Q2 2021, and $3.2 million during Q1 2021.